Table 2. Multivariable Linear Mixed Effects Regression Analysis of Pulse Rate and Blood Pressure in Malaria Following Treatment with Amodiaquine.
Pulse Rate (beats/minute) | Systolic Blood Pressure – Supine (mmHg) | Diastolic Blood Pressure – Erect (mmHg) | |||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Univariable Analyses | Multivariable Analyses | Univariable Analyses | Multivariable Analyses | Univariable Analyses | Multivariable Analyses | ||||||||
Number of Observations | Crude Estimate (95% CI) | p value | Adjusted Estimate (95% CI) | p value | Crude Estimate (95% CI) | p value | Adjusted Estimate (95% CI) | p value | Crude Estimate (95% CI) | p value | Adjusted Estimate (95% CI) | p value | |
Total plasma concentration of amodiaquine and desethylamodiaquine, per 750* nmol/litre increase | 362 | -19.51 (-23.10 to -15.92) | <0.0001 | -14.57 (-18.22 to -10.92) | <0.0001 | -18.09 (-20.99 to -15.20) | <0.0001 | -12.43 (-15.95 to -8.92) | <0.0001 | -10.64 (-13.03 to -8.25) | <0.0001 | -10.26 (-13.11 to -7.42) | <0.0001 |
Body temperature change, per 1°C increase | 362 | 9.72 (8.32 to 11.12) | <0.0001 | 5.65 (3.74 to 7.56) | <0.0001 | 4.46 (3.14 to 5.79) | <0.0001 | 2.97 (1.94 to 4.00) | <0.0001 | ||||
Malaria | 362 | ||||||||||||
Yes (days 0-2) | 106 | -3.21 (-5.54 to -0.90) | 0.0066 | 2.98 (0.50 to 5.46) | 0.0186 | -9.41 (-11.52 to -7.30) | <0.0001 | -4.53 (-6.93 to -2.13) | 0.0002 | -1.13 (-2.84 to 0.58) | 0.1958 | 2.91 (0.97 to 4.85) | 0.0034 |
No (days 3-28) | 256 | Reference | Reference | Reference | Reference | Reference | Reference | ||||||
Sex | 362 | ||||||||||||
Female | 193 | Reference | Reference | Reference | Reference | ||||||||
Male | 169 | 3.06 (-4.81 to 10.93) | 0.4388 | 4.12 (-4.17 to 12.41) | 0.3232 | 2.52 (-3.74 to 8.78) | 0.4231 | 4.14 (-0.80 to 9.08) | 0.0985 |
Mean maximum total plasma drug concentration (rounded) after a 3-day course of amodiaquine from pharmacokinetic analysis of same study